<?xml version="1.0" encoding="utf-8"?>
<Return xmlns="http://www.irs.gov/efile" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" returnVersion="2021v4.1" xsi:schemaLocation="http://www.irs.gov/efile">
  <ReturnHeader binaryAttachmentCnt="0">
    <ReturnTs>2023-03-20T20:56:19-07:00</ReturnTs>
    <TaxPeriodEndDt>2022-06-30</TaxPeriodEndDt>
    <PreparerFirmGrp>
      <PreparerFirmEIN>464370753</PreparerFirmEIN>
      <PreparerFirmName>
        <BusinessNameLine1Txt>Baldwin Moffitt Behm LLP</BusinessNameLine1Txt>
      </PreparerFirmName>
      <PreparerUSAddress>
        <AddressLine1Txt>8399 E Indian School Rd Suite 201</AddressLine1Txt>
        <CityNm>Scottsdale</CityNm>
        <StateAbbreviationCd>AZ</StateAbbreviationCd>
        <ZIPCd>85251</ZIPCd>
      </PreparerUSAddress>
    </PreparerFirmGrp>
    <ReturnTypeCd>990</ReturnTypeCd>
    <TaxPeriodBeginDt>2021-07-01</TaxPeriodBeginDt>
    <Filer>
      <EIN>203771288</EIN>
      <BusinessName>
        <BusinessNameLine1Txt>CANCER AWARENESS THROUGH RESEARCH</BusinessNameLine1Txt>
        <BusinessNameLine2Txt>AND EDUCATION CARE</BusinessNameLine2Txt>
      </BusinessName>
      <BusinessNameControlTxt>CANC</BusinessNameControlTxt>
      <PhoneNum>9522217432</PhoneNum>
      <USAddress>
        <AddressLine1Txt>PO BOX 3740</AddressLine1Txt>
        <CityNm>CAREFREE</CityNm>
        <StateAbbreviationCd>AZ</StateAbbreviationCd>
        <ZIPCd>85377</ZIPCd>
      </USAddress>
    </Filer>
    <BusinessOfficerGrp>
      <PersonNm>J DEREK HILL</PersonNm>
      <PersonTitleTxt>Treasurer</PersonTitleTxt>
      <SignatureDt>2023-03-20</SignatureDt>
      <DiscussWithPaidPreparerInd>true</DiscussWithPaidPreparerInd>
    </BusinessOfficerGrp>
    <SigningOfficerGrp>
      <PersonFullName>
        <PersonFirstNm>J DEREK</PersonFirstNm>
        <PersonLastNm>HILL</PersonLastNm>
      </PersonFullName>
      <SSN>999009999</SSN>
    </SigningOfficerGrp>
    <PreparerPersonGrp>
      <PreparerPersonNm>David Baldwin</PreparerPersonNm>
      <PTIN>P00184135</PTIN>
      <PhoneNum>4807369200</PhoneNum>
    </PreparerPersonGrp>
    <AdditionalFilerInformation>
      <TrustedCustomerGrp>
        <TrustedCustomerCd>2</TrustedCustomerCd>
        <AuthenticationAssuranceLevelCd>AAL1</AuthenticationAssuranceLevelCd>
        <IdentityAssuranceLevelCd>IAL1</IdentityAssuranceLevelCd>
        <FederatedAssuranceLevelCd>FAL1</FederatedAssuranceLevelCd>
      </TrustedCustomerGrp>
    </AdditionalFilerInformation>
    <TaxYr>2021</TaxYr>
    <BuildTS>2023-04-26 12:10:37Z</BuildTS>
  </ReturnHeader>
  <ReturnData documentCnt="6">
    <IRS990 documentId="IRS990" referenceDocumentId="IRS990ScheduleO" softwareId="21013475" softwareVersionNum="2021v4.1">
      <PrincipalOfficerNm>Jill Porcellato</PrincipalOfficerNm>
      <USAddress>
        <AddressLine1Txt>10517 E PALO BREA DRIVE</AddressLine1Txt>
        <CityNm>SCOTTSDALE</CityNm>
        <StateAbbreviationCd>AZ</StateAbbreviationCd>
        <ZIPCd>85262</ZIPCd>
      </USAddress>
      <GrossReceiptsAmt>1232017</GrossReceiptsAmt>
      <GroupReturnForAffiliatesInd>false</GroupReturnForAffiliatesInd>
      <Organization501c3Ind>X</Organization501c3Ind>
      <WebsiteAddressTxt>WWW.CAREDM.ORG</WebsiteAddressTxt>
      <TypeOfOrganizationCorpInd>X</TypeOfOrganizationCorpInd>
      <FormationYr>2005</FormationYr>
      <LegalDomicileStateCd>AZ</LegalDomicileStateCd>
      <ActivityOrMissionDesc>CARE PROMOTES AWARENESS ABOUT CANCER TREATMENT AND PREVENTION THROUGH EDUCATIONALFORUMS AND SEMINARS AND RAISES MONEY TO PROVIDE SEED-FUNDING TO FUND INNOVATIVE NEW CANCER RESEARCH PROJECTS AND CLINICAL TRIALS IN THE PHOENIX AREA.</ActivityOrMissionDesc>
      <VotingMembersGoverningBodyCnt>7</VotingMembersGoverningBodyCnt>
      <VotingMembersIndependentCnt>0</VotingMembersIndependentCnt>
      <TotalEmployeeCnt>0</TotalEmployeeCnt>
      <TotalVolunteersCnt>90</TotalVolunteersCnt>
      <TotalGrossUBIAmt>0</TotalGrossUBIAmt>
      <PYContributionsGrantsAmt>563708</PYContributionsGrantsAmt>
      <CYContributionsGrantsAmt>1085260</CYContributionsGrantsAmt>
      <PYProgramServiceRevenueAmt>5463</PYProgramServiceRevenueAmt>
      <CYProgramServiceRevenueAmt>0</CYProgramServiceRevenueAmt>
      <PYInvestmentIncomeAmt>72</PYInvestmentIncomeAmt>
      <CYInvestmentIncomeAmt>-155</CYInvestmentIncomeAmt>
      <PYOtherRevenueAmt>-30917</PYOtherRevenueAmt>
      <CYOtherRevenueAmt>-115970</CYOtherRevenueAmt>
      <PYTotalRevenueAmt>538326</PYTotalRevenueAmt>
      <CYTotalRevenueAmt>969135</CYTotalRevenueAmt>
      <PYGrantsAndSimilarPaidAmt>500000</PYGrantsAndSimilarPaidAmt>
      <CYGrantsAndSimilarPaidAmt>880000</CYGrantsAndSimilarPaidAmt>
      <CYBenefitsPaidToMembersAmt>0</CYBenefitsPaidToMembersAmt>
      <CYSalariesCompEmpBnftPaidAmt>0</CYSalariesCompEmpBnftPaidAmt>
      <CYTotalProfFndrsngExpnsAmt>0</CYTotalProfFndrsngExpnsAmt>
      <CYTotalFundraisingExpenseAmt>14715</CYTotalFundraisingExpenseAmt>
      <PYOtherExpensesAmt>20757</PYOtherExpensesAmt>
      <CYOtherExpensesAmt>25955</CYOtherExpensesAmt>
      <PYTotalExpensesAmt>520757</PYTotalExpensesAmt>
      <CYTotalExpensesAmt>905955</CYTotalExpensesAmt>
      <PYRevenuesLessExpensesAmt>17569</PYRevenuesLessExpensesAmt>
      <CYRevenuesLessExpensesAmt>63180</CYRevenuesLessExpensesAmt>
      <TotalAssetsBOYAmt>85272</TotalAssetsBOYAmt>
      <TotalAssetsEOYAmt>148453</TotalAssetsEOYAmt>
      <TotalLiabilitiesBOYAmt>5672</TotalLiabilitiesBOYAmt>
      <TotalLiabilitiesEOYAmt>0</TotalLiabilitiesEOYAmt>
      <NetAssetsOrFundBalancesBOYAmt>79600</NetAssetsOrFundBalancesBOYAmt>
      <NetAssetsOrFundBalancesEOYAmt>148453</NetAssetsOrFundBalancesEOYAmt>
      <MissionDesc>CARE PROMOTES AWARENESS ABOUT CANCER TREATMENT AND PREVENTION THROUGH EDUCATIONALFORUMS AND SEMINARS AND RAISES MONEY TO PROVIDE SEED-FUNDING TO FUND INNOVATIVE NEW CANCER RESEARCH PROJECTS AND CLINICAL TRIALS IN THE PHOENIX AREA.</MissionDesc>
      <SignificantNewProgramSrvcInd>false</SignificantNewProgramSrvcInd>
      <SignificantChangeInd>false</SignificantChangeInd>
      <ExpenseAmt>440000</ExpenseAmt>
      <GrantAmt>440000</GrantAmt>
      <Desc>Mayo Clinic in AZ - Funding two Mayo Clinic projects: 1) Predicting Metastatic Potential Cutaneous Squamous Cell Carcinoma, and 2) Targeting Metastatic Prostate Cancer With Novel Fn14Predicting Metatasic Potential Cutaneous Squamous Cell Carcinoma Using Gene Expression Profiling:Cutaneous squamous cell carcinoma (cSCC) affects more than one million individuals annually in the United States. Its incidence is rising due to ultraviolet exposure and an increase in the population of elderly and immunosuppressed individuals. Most cSCC is curable by surgery, but metastasis occurs in up to 5% of patients. Metastatic cSCC carries a poor five-year survival (25-35%) and accounts for nearly 8,800 deaths annually, comparable to the mortality rate of malignant melanoma.There is a great need for more accurate identification of tumors with metastatic potential to truly characterize cSCC patients that are at high risk. Mayo Clinics research team has developed a method based on gene expression profiling (GEP) that can stratify intermediate to high-risk cSCC for overall survival by 20-fold and can properly stratify 95% of intermediate to high-risk tumors as non-metastatic and 70% of intermediate to high-risk tumors as metastatic. Validation of this panel would permit design of not only a new test, but an entire new way of assessing the risk in one of the most common human cancers, SCC.Targeting Metastatic Prostate Cancer With Novel Fn14 Inhibitory Compound:Prostate cancer (PCa) is the second leading cause of cancer related death in American men. Like normal prostate tissue, which requires androgen hormones produced by the body to function, so do prostate cancer cells. Thus, treatment for PCa frequently involves either reducing the supply of androgens by blocking androgen synthesis in the body or disrupting the stimulation of cancer cells through blockade of androgen receptor signals in cancer cells. This approach is known as androgen deprivation therapy (ADT). Although initial response rates are promising, all men eventually progress on ADT and develop a resistant version of prostate cancer, which undergoes metastatic spread. At this metastatic stage, specifically when metastasized to the bone, PCa is incurable, and an increasing number of men are developing a highly lethal variant of PCa known as aggressive variant prostate cancer (AVPC). Androgen receptor signaling is lost in AVPC rendering the existing hormone targeting treatments ineffective. To date, very few therapies exist for AVPC and only offer minimal survival benefits in this setting. Thus, the identification and assessment of drug targeting VAPC are needed to effectively treat and control metastasis.</Desc>
      <ProgSrvcAccomActy2Grp>
        <ExpenseAmt>440000</ExpenseAmt>
        <GrantAmt>440000</GrantAmt>
        <Desc>HonorHealth Research Institute - Funding two HHRI projects: 1) Uveal Melanoma Study, and 2) Tenosynovial Giant Cell Tumor StudyUveal Melanoma:Uveal melanoma (UM) is a rare subtype that arises typically in the choroidal body of the eye. Unlike cutaneous (skin) melanoma, UM has been resistant to current immunotherapy and at the present time, there is no FDA approved treatment for this disease making it both a rare and refractory disease. HHRIs goal is to identify novel biomarkers for disease monitoring and diagnosis with the expectation that such biomarkers can be used to identify patients at highest risk for recurrence and utilize these biomarkers as a surrogate endpoint in the adjuvant setting.Tenosynovial Giant Cell Tumor: Tenosynovial giant cell tumor (TGCT) is a rare sarcomatous proliferation of the synovium lining the joints. This disorder typically occurs in young men and women and most often impact the large joints, particularly the knees.By the time patients present for diagnosis, the TGCT proliferation if most often not completely resectable and surgery has limited value. MRI scans have classical features for this diagnosis but suffer from inaccuracy and the fact that a tissue diagnosis is needed to move forward with systemic therapy. Treatment for TGCT includes the orally administered targeted drug pexidartinib which can be associated with the development of liver failure making its use somewhat complex. The lack of a simple diagnostic test, as opposed to having to proceed with surgery and biopsy, places patients at greater risk for complications. We have identified this as a potentially game-changing opportunity since most of these patients present not only with the synovial proliferation but also with a detectable joint effusion (fluid) that can be aspirated. HHRI is proposing to subject new diagnosed and untreated patients to a joint effusion aspiration as well as the necessary surgical biopsy (if not already performed) to develop an effusion-driven biomarker analysis allowing an alternate mechanism for securing the diagnosis of TGCT</Desc>
      </ProgSrvcAccomActy2Grp>
      <TotalProgramServiceExpensesAmt>880000</TotalProgramServiceExpensesAmt>
      <DescribedInSection501c3Ind referenceDocumentId="IRS990ScheduleA">true</DescribedInSection501c3Ind>
      <ScheduleBRequiredInd referenceDocumentId="IRS990ScheduleB">true</ScheduleBRequiredInd>
      <PoliticalCampaignActyInd>false</PoliticalCampaignActyInd>
      <LobbyingActivitiesInd>false</LobbyingActivitiesInd>
      <SubjectToProxyTaxInd>false</SubjectToProxyTaxInd>
      <DonorAdvisedFundInd>false</DonorAdvisedFundInd>
      <ConservationEasementsInd>false</ConservationEasementsInd>
      <CollectionsOfArtInd>false</CollectionsOfArtInd>
      <CreditCounselingInd>false</CreditCounselingInd>
      <DonorRstrOrQuasiEndowmentsInd>false</DonorRstrOrQuasiEndowmentsInd>
      <ReportLandBuildingEquipmentInd>false</ReportLandBuildingEquipmentInd>
      <ReportInvestmentsOtherSecInd>false</ReportInvestmentsOtherSecInd>
      <ReportProgramRelatedInvstInd>false</ReportProgramRelatedInvstInd>
      <ReportOtherAssetsInd>false</ReportOtherAssetsInd>
      <ReportOtherLiabilitiesInd>false</ReportOtherLiabilitiesInd>
      <IncludeFIN48FootnoteInd>false</IncludeFIN48FootnoteInd>
      <IndependentAuditFinclStmtInd>false</IndependentAuditFinclStmtInd>
      <ConsolidatedAuditFinclStmtInd>false</ConsolidatedAuditFinclStmtInd>
      <SchoolOperatingInd>false</SchoolOperatingInd>
      <ForeignOfficeInd>false</ForeignOfficeInd>
      <ForeignActivitiesInd>false</ForeignActivitiesInd>
      <MoreThan5000KToOrgInd>false</MoreThan5000KToOrgInd>
      <MoreThan5000KToIndividualsInd>false</MoreThan5000KToIndividualsInd>
      <ProfessionalFundraisingInd referenceDocumentId="IRS990ScheduleG">false</ProfessionalFundraisingInd>
      <FundraisingActivitiesInd referenceDocumentId="IRS990ScheduleG">true</FundraisingActivitiesInd>
      <GamingActivitiesInd referenceDocumentId="IRS990ScheduleG">true</GamingActivitiesInd>
      <OperateHospitalInd>false</OperateHospitalInd>
      <GrantsToOrganizationsInd referenceDocumentId="IRS990ScheduleI">true</GrantsToOrganizationsInd>
      <GrantsToIndividualsInd referenceDocumentId="IRS990ScheduleI">false</GrantsToIndividualsInd>
      <ScheduleJRequiredInd>false</ScheduleJRequiredInd>
      <TaxExemptBondsInd>false</TaxExemptBondsInd>
      <EngagedInExcessBenefitTransInd>false</EngagedInExcessBenefitTransInd>
      <PYExcessBenefitTransInd>false</PYExcessBenefitTransInd>
      <LoanOutstandingInd>false</LoanOutstandingInd>
      <GrantToRelatedPersonInd>false</GrantToRelatedPersonInd>
      <BusinessRlnWithOrgMemInd>false</BusinessRlnWithOrgMemInd>
      <BusinessRlnWithFamMemInd>false</BusinessRlnWithFamMemInd>
      <BusinessRlnWith35CtrlEntInd>false</BusinessRlnWith35CtrlEntInd>
      <DeductibleNonCashContriInd>false</DeductibleNonCashContriInd>
      <DeductibleArtContributionInd>false</DeductibleArtContributionInd>
      <TerminateOperationsInd>false</TerminateOperationsInd>
      <PartialLiquidationInd>false</PartialLiquidationInd>
      <DisregardedEntityInd>false</DisregardedEntityInd>
      <RelatedEntityInd>false</RelatedEntityInd>
      <RelatedOrganizationCtrlEntInd>false</RelatedOrganizationCtrlEntInd>
      <TrnsfrExmptNonChrtblRltdOrgInd>false</TrnsfrExmptNonChrtblRltdOrgInd>
      <ActivitiesConductedPrtshpInd>false</ActivitiesConductedPrtshpInd>
      <ScheduleORequiredInd>true</ScheduleORequiredInd>
      <IRPDocumentCnt>3</IRPDocumentCnt>
      <IRPDocumentW2GCnt>0</IRPDocumentW2GCnt>
      <BackupWthldComplianceInd>false</BackupWthldComplianceInd>
      <EmployeeCnt>0</EmployeeCnt>
      <UnrelatedBusIncmOverLimitInd>false</UnrelatedBusIncmOverLimitInd>
      <ForeignFinancialAccountInd>false</ForeignFinancialAccountInd>
      <ProhibitedTaxShelterTransInd>false</ProhibitedTaxShelterTransInd>
      <TaxablePartyNotificationInd>false</TaxablePartyNotificationInd>
      <NondeductibleContributionsInd>false</NondeductibleContributionsInd>
      <QuidProQuoContributionsInd>false</QuidProQuoContributionsInd>
      <Form8282PropertyDisposedOfInd>false</Form8282PropertyDisposedOfInd>
      <Form8282FiledCnt>0</Form8282FiledCnt>
      <RcvFndsToPayPrsnlBnftCntrctInd>false</RcvFndsToPayPrsnlBnftCntrctInd>
      <PayPremiumsPrsnlBnftCntrctInd>false</PayPremiumsPrsnlBnftCntrctInd>
      <Form8899Filedind>false</Form8899Filedind>
      <Form1098CFiledInd>false</Form1098CFiledInd>
      <IndoorTanningServicesInd>false</IndoorTanningServicesInd>
      <SubjToTaxRmnrtnExPrchtPymtInd>false</SubjToTaxRmnrtnExPrchtPymtInd>
      <SubjectToExcsTaxNetInvstIncInd>false</SubjectToExcsTaxNetInvstIncInd>
      <InfoInScheduleOPartVIInd>X</InfoInScheduleOPartVIInd>
      <GoverningBodyVotingMembersCnt>7</GoverningBodyVotingMembersCnt>
      <IndependentVotingMemberCnt>0</IndependentVotingMemberCnt>
      <FamilyOrBusinessRlnInd>false</FamilyOrBusinessRlnInd>
      <DelegationOfMgmtDutiesInd>false</DelegationOfMgmtDutiesInd>
      <ChangeToOrgDocumentsInd>false</ChangeToOrgDocumentsInd>
      <MaterialDiversionOrMisuseInd>false</MaterialDiversionOrMisuseInd>
      <MembersOrStockholdersInd>false</MembersOrStockholdersInd>
      <ElectionOfBoardMembersInd>false</ElectionOfBoardMembersInd>
      <DecisionsSubjectToApprovaInd>false</DecisionsSubjectToApprovaInd>
      <MinutesOfGoverningBodyInd>true</MinutesOfGoverningBodyInd>
      <MinutesOfCommitteesInd>true</MinutesOfCommitteesInd>
      <OfficerMailingAddressInd>false</OfficerMailingAddressInd>
      <LocalChaptersInd>false</LocalChaptersInd>
      <Form990ProvidedToGvrnBodyInd>true</Form990ProvidedToGvrnBodyInd>
      <ConflictOfInterestPolicyInd>true</ConflictOfInterestPolicyInd>
      <AnnualDisclosureCoveredPrsnInd>true</AnnualDisclosureCoveredPrsnInd>
      <RegularMonitoringEnfrcInd>true</RegularMonitoringEnfrcInd>
      <WhistleblowerPolicyInd>true</WhistleblowerPolicyInd>
      <DocumentRetentionPolicyInd>true</DocumentRetentionPolicyInd>
      <CompensationProcessCEOInd>false</CompensationProcessCEOInd>
      <CompensationProcessOtherInd>false</CompensationProcessOtherInd>
      <InvestmentInJointVentureInd>false</InvestmentInJointVentureInd>
      <UponRequestInd>X</UponRequestInd>
      <BooksInCareOfDetail>
        <PersonNm>J DEREK HILL</PersonNm>
        <PhoneNum>4808287653</PhoneNum>
        <USAddress>
          <AddressLine1Txt>PO Box 3740</AddressLine1Txt>
          <CityNm>Carefree</CityNm>
          <StateAbbreviationCd>AZ</StateAbbreviationCd>
          <ZIPCd>85377</ZIPCd>
        </USAddress>
      </BooksInCareOfDetail>
      <NoListedPersonsCompensatedInd>X</NoListedPersonsCompensatedInd>
      <Form990PartVIISectionAGrp>
        <PersonNm>Michael Blaszyk</PersonNm>
        <TitleTxt>Director</TitleTxt>
        <AverageHoursPerWeekRt>15.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.00</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Syliva Owens</PersonNm>
        <TitleTxt>Director</TitleTxt>
        <AverageHoursPerWeekRt>2.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.00</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Wayne Malloux</PersonNm>
        <TitleTxt>Director</TitleTxt>
        <AverageHoursPerWeekRt>5.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.00</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Mary Wendt Moase</PersonNm>
        <TitleTxt>Director</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.00</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Jill Porcellato</PersonNm>
        <TitleTxt>Chairman</TitleTxt>
        <AverageHoursPerWeekRt>30.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.00</AverageHoursPerWeekRltdOrgRt>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>J DEREK HILL</PersonNm>
        <TitleTxt>Treasurer</TitleTxt>
        <AverageHoursPerWeekRt>20.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.00</AverageHoursPerWeekRltdOrgRt>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Suzanne Paetzer</PersonNm>
        <TitleTxt>vice Chair/Secr</TitleTxt>
        <AverageHoursPerWeekRt>30.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.00</AverageHoursPerWeekRltdOrgRt>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <IndivRcvdGreaterThan100KCnt>0</IndivRcvdGreaterThan100KCnt>
      <FormerOfcrEmployeesListedInd>false</FormerOfcrEmployeesListedInd>
      <TotalCompGreaterThan150KInd>false</TotalCompGreaterThan150KInd>
      <CompensationFromOtherSrcsInd>false</CompensationFromOtherSrcsInd>
      <CntrctRcvdGreaterThan100KCnt>0</CntrctRcvdGreaterThan100KCnt>
      <FundraisingAmt>359830</FundraisingAmt>
      <AllOtherContributionsAmt>725430</AllOtherContributionsAmt>
      <TotalContributionsAmt>1085260</TotalContributionsAmt>
      <TotalProgramServiceRevenueAmt>0</TotalProgramServiceRevenueAmt>
      <InvestmentIncomeGrp>
        <TotalRevenueColumnAmt>28</TotalRevenueColumnAmt>
        <ExclusionAmt>28</ExclusionAmt>
      </InvestmentIncomeGrp>
      <IncmFromInvestBondProceedsGrp>
        <TotalRevenueColumnAmt>0</TotalRevenueColumnAmt>
      </IncmFromInvestBondProceedsGrp>
      <RoyaltiesRevenueGrp>
        <TotalRevenueColumnAmt>0</TotalRevenueColumnAmt>
      </RoyaltiesRevenueGrp>
      <NetRentalIncomeOrLossGrp>
        <TotalRevenueColumnAmt>0</TotalRevenueColumnAmt>
      </NetRentalIncomeOrLossGrp>
      <GrossAmountSalesAssetsGrp>
        <SecuritiesAmt>28334</SecuritiesAmt>
      </GrossAmountSalesAssetsGrp>
      <LessCostOthBasisSalesExpnssGrp>
        <SecuritiesAmt>28517</SecuritiesAmt>
      </LessCostOthBasisSalesExpnssGrp>
      <GainOrLossGrp>
        <SecuritiesAmt>-183</SecuritiesAmt>
      </GainOrLossGrp>
      <NetGainOrLossInvestmentsGrp>
        <TotalRevenueColumnAmt>-183</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>-183</RelatedOrExemptFuncIncomeAmt>
      </NetGainOrLossInvestmentsGrp>
      <FundraisingGrossIncomeAmt>68700</FundraisingGrossIncomeAmt>
      <ContriRptFundraisingEventAmt>359830</ContriRptFundraisingEventAmt>
      <FundraisingDirectExpensesAmt>234365</FundraisingDirectExpensesAmt>
      <NetIncmFromFundraisingEvtGrp>
        <TotalRevenueColumnAmt>-165665</TotalRevenueColumnAmt>
      </NetIncmFromFundraisingEvtGrp>
      <GamingGrossIncomeAmt>49695</GamingGrossIncomeAmt>
      <NetIncomeFromGamingGrp>
        <TotalRevenueColumnAmt>49695</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>-420000</RelatedOrExemptFuncIncomeAmt>
      </NetIncomeFromGamingGrp>
      <NetIncomeOrLossGrp>
        <TotalRevenueColumnAmt>0</TotalRevenueColumnAmt>
      </NetIncomeOrLossGrp>
      <OtherRevenueTotalAmt>0</OtherRevenueTotalAmt>
      <TotalRevenueGrp>
        <TotalRevenueColumnAmt>969135</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>-420183</RelatedOrExemptFuncIncomeAmt>
        <ExclusionAmt>28</ExclusionAmt>
      </TotalRevenueGrp>
      <GrantsToDomesticOrgsGrp>
        <TotalAmt>880000</TotalAmt>
        <ProgramServicesAmt>880000</ProgramServicesAmt>
      </GrantsToDomesticOrgsGrp>
      <GrantsToDomesticIndividualsGrp>
        <TotalAmt>0</TotalAmt>
      </GrantsToDomesticIndividualsGrp>
      <ForeignGrantsGrp>
        <TotalAmt>0</TotalAmt>
      </ForeignGrantsGrp>
      <BenefitsToMembersGrp>
        <TotalAmt>0</TotalAmt>
      </BenefitsToMembersGrp>
      <CompCurrentOfcrDirectorsGrp>
        <TotalAmt>0</TotalAmt>
      </CompCurrentOfcrDirectorsGrp>
      <CompDisqualPersonsGrp>
        <TotalAmt>0</TotalAmt>
      </CompDisqualPersonsGrp>
      <OtherSalariesAndWagesGrp>
        <TotalAmt>0</TotalAmt>
      </OtherSalariesAndWagesGrp>
      <PensionPlanContributionsGrp>
        <TotalAmt>0</TotalAmt>
      </PensionPlanContributionsGrp>
      <OtherEmployeeBenefitsGrp>
        <TotalAmt>0</TotalAmt>
      </OtherEmployeeBenefitsGrp>
      <PayrollTaxesGrp>
        <TotalAmt>0</TotalAmt>
      </PayrollTaxesGrp>
      <FeesForServicesManagementGrp>
        <TotalAmt>0</TotalAmt>
      </FeesForServicesManagementGrp>
      <FeesForServicesLegalGrp>
        <TotalAmt>10</TotalAmt>
        <ManagementAndGeneralAmt>10</ManagementAndGeneralAmt>
      </FeesForServicesLegalGrp>
      <FeesForServicesAccountingGrp>
        <TotalAmt>4517</TotalAmt>
        <ManagementAndGeneralAmt>4517</ManagementAndGeneralAmt>
      </FeesForServicesAccountingGrp>
      <FeesForServicesLobbyingGrp>
        <TotalAmt>0</TotalAmt>
      </FeesForServicesLobbyingGrp>
      <FeesForServicesProfFundraising>
        <TotalAmt>0</TotalAmt>
      </FeesForServicesProfFundraising>
      <FeesForSrvcInvstMgmntFeesGrp>
        <TotalAmt>0</TotalAmt>
      </FeesForSrvcInvstMgmntFeesGrp>
      <FeesForServicesOtherGrp>
        <TotalAmt>0</TotalAmt>
      </FeesForServicesOtherGrp>
      <AdvertisingGrp>
        <TotalAmt>251</TotalAmt>
        <ManagementAndGeneralAmt>251</ManagementAndGeneralAmt>
      </AdvertisingGrp>
      <OfficeExpensesGrp>
        <TotalAmt>160</TotalAmt>
        <ManagementAndGeneralAmt>160</ManagementAndGeneralAmt>
      </OfficeExpensesGrp>
      <InformationTechnologyGrp>
        <TotalAmt>0</TotalAmt>
      </InformationTechnologyGrp>
      <RoyaltiesGrp>
        <TotalAmt>0</TotalAmt>
      </RoyaltiesGrp>
      <OccupancyGrp>
        <TotalAmt>0</TotalAmt>
      </OccupancyGrp>
      <TravelGrp>
        <TotalAmt>0</TotalAmt>
      </TravelGrp>
      <PymtTravelEntrtnmntPubOfclGrp>
        <TotalAmt>0</TotalAmt>
      </PymtTravelEntrtnmntPubOfclGrp>
      <ConferencesMeetingsGrp>
        <TotalAmt>0</TotalAmt>
      </ConferencesMeetingsGrp>
      <InterestGrp>
        <TotalAmt>0</TotalAmt>
      </InterestGrp>
      <PaymentsToAffiliatesGrp>
        <TotalAmt>0</TotalAmt>
      </PaymentsToAffiliatesGrp>
      <DepreciationDepletionGrp>
        <TotalAmt>0</TotalAmt>
      </DepreciationDepletionGrp>
      <InsuranceGrp>
        <TotalAmt>1594</TotalAmt>
        <ManagementAndGeneralAmt>1594</ManagementAndGeneralAmt>
      </InsuranceGrp>
      <OtherExpensesGrp>
        <Desc>Printing and Publications</Desc>
        <TotalAmt>14951</TotalAmt>
        <ManagementAndGeneralAmt>236</ManagementAndGeneralAmt>
        <FundraisingAmt>14715</FundraisingAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>Postage and Shipping</Desc>
        <TotalAmt>4277</TotalAmt>
        <ManagementAndGeneralAmt>4277</ManagementAndGeneralAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>Bank Charges</Desc>
        <TotalAmt>110</TotalAmt>
        <ManagementAndGeneralAmt>110</ManagementAndGeneralAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>Storage rental</Desc>
        <TotalAmt>64</TotalAmt>
        <ManagementAndGeneralAmt>64</ManagementAndGeneralAmt>
      </OtherExpensesGrp>
      <AllOtherExpensesGrp>
        <TotalAmt>21</TotalAmt>
        <ManagementAndGeneralAmt>21</ManagementAndGeneralAmt>
      </AllOtherExpensesGrp>
      <TotalFunctionalExpensesGrp>
        <TotalAmt>905955</TotalAmt>
        <ProgramServicesAmt>880000</ProgramServicesAmt>
        <ManagementAndGeneralAmt>11240</ManagementAndGeneralAmt>
        <FundraisingAmt>14715</FundraisingAmt>
      </TotalFunctionalExpensesGrp>
      <CashNonInterestBearingGrp>
        <BOYAmt>31697</BOYAmt>
        <EOYAmt>22899</EOYAmt>
      </CashNonInterestBearingGrp>
      <SavingsAndTempCashInvstGrp>
        <BOYAmt>48283</BOYAmt>
        <EOYAmt>125028</EOYAmt>
      </SavingsAndTempCashInvstGrp>
      <PledgesAndGrantsReceivableGrp>
        <EOYAmt>0</EOYAmt>
      </PledgesAndGrantsReceivableGrp>
      <AccountsReceivableGrp>
        <EOYAmt>0</EOYAmt>
      </AccountsReceivableGrp>
      <ReceivablesFromOfficersEtcGrp>
        <EOYAmt>0</EOYAmt>
      </ReceivablesFromOfficersEtcGrp>
      <RcvblFromDisqualifiedPrsnGrp>
        <EOYAmt>0</EOYAmt>
      </RcvblFromDisqualifiedPrsnGrp>
      <OthNotesLoansReceivableNetGrp>
        <EOYAmt>0</EOYAmt>
      </OthNotesLoansReceivableNetGrp>
      <InventoriesForSaleOrUseGrp>
        <EOYAmt>0</EOYAmt>
      </InventoriesForSaleOrUseGrp>
      <PrepaidExpensesDefrdChargesGrp>
        <EOYAmt>0</EOYAmt>
      </PrepaidExpensesDefrdChargesGrp>
      <LandBldgEquipBasisNetGrp>
        <EOYAmt>0</EOYAmt>
      </LandBldgEquipBasisNetGrp>
      <InvestmentsPubTradedSecGrp>
        <BOYAmt>5292</BOYAmt>
        <EOYAmt>526</EOYAmt>
      </InvestmentsPubTradedSecGrp>
      <InvestmentsOtherSecuritiesGrp>
        <EOYAmt>0</EOYAmt>
      </InvestmentsOtherSecuritiesGrp>
      <InvestmentsProgramRelatedGrp>
        <EOYAmt>0</EOYAmt>
      </InvestmentsProgramRelatedGrp>
      <IntangibleAssetsGrp>
        <EOYAmt>0</EOYAmt>
      </IntangibleAssetsGrp>
      <OtherAssetsTotalGrp>
        <EOYAmt>0</EOYAmt>
      </OtherAssetsTotalGrp>
      <TotalAssetsGrp>
        <BOYAmt>85272</BOYAmt>
        <EOYAmt>148453</EOYAmt>
      </TotalAssetsGrp>
      <AccountsPayableAccrExpnssGrp>
        <BOYAmt>5672</BOYAmt>
      </AccountsPayableAccrExpnssGrp>
      <TotalLiabilitiesGrp>
        <BOYAmt>5672</BOYAmt>
        <EOYAmt>0</EOYAmt>
      </TotalLiabilitiesGrp>
      <OrganizationFollowsFASB117Ind>X</OrganizationFollowsFASB117Ind>
      <NoDonorRestrictionNetAssetsGrp>
        <BOYAmt>79600</BOYAmt>
        <EOYAmt>148453</EOYAmt>
      </NoDonorRestrictionNetAssetsGrp>
      <TotalNetAssetsFundBalanceGrp>
        <BOYAmt>79600</BOYAmt>
        <EOYAmt>148453</EOYAmt>
      </TotalNetAssetsFundBalanceGrp>
      <TotLiabNetAssetsFundBalanceGrp>
        <BOYAmt>85272</BOYAmt>
        <EOYAmt>148453</EOYAmt>
      </TotLiabNetAssetsFundBalanceGrp>
      <InfoInScheduleOPartXIInd>X</InfoInScheduleOPartXIInd>
      <ReconcilationRevenueExpnssAmt>63180</ReconcilationRevenueExpnssAmt>
      <OtherChangesInNetAssetsAmt>5673</OtherChangesInNetAssetsAmt>
      <InfoInScheduleOPartXIIInd>X</InfoInScheduleOPartXIIInd>
      <MethodOfAccountingOtherInd methodOfAccountingOtherDesc="MODFIED CASH">X</MethodOfAccountingOtherInd>
      <AccountantCompileOrReviewInd>false</AccountantCompileOrReviewInd>
      <FSAuditedInd>false</FSAuditedInd>
      <FederalGrantAuditRequiredInd>false</FederalGrantAuditRequiredInd>
    </IRS990>
    <IRS990ScheduleA documentId="IRS990ScheduleA" softwareId="21013475" softwareVersionNum="2021v4.1">
      <PubliclySupportedOrg509a2Ind>X</PubliclySupportedOrg509a2Ind>
      <GiftsGrantsContrisRcvd509Grp>
        <CurrentTaxYearMinus4YearsAmt>476210</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>470567</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>604016</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>563708</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>1085260</CurrentTaxYearAmt>
        <TotalAmt>3199761</TotalAmt>
      </GiftsGrantsContrisRcvd509Grp>
      <GrossReceiptsAdmissionsGrp>
        <CurrentTaxYearMinus4YearsAmt>177259</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>113753</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>209237</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>68888</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>68700</CurrentTaxYearAmt>
        <TotalAmt>637837</TotalAmt>
      </GrossReceiptsAdmissionsGrp>
      <GrossReceiptsNonUnrltBusGrp>
        <TotalAmt>0</TotalAmt>
      </GrossReceiptsNonUnrltBusGrp>
      <TaxRevLeviedOrgnztnlBnft509Grp>
        <TotalAmt>0</TotalAmt>
      </TaxRevLeviedOrgnztnlBnft509Grp>
      <GovtFurnSrvcFcltsVl509Grp>
        <TotalAmt>0</TotalAmt>
      </GovtFurnSrvcFcltsVl509Grp>
      <Total509Grp>
        <CurrentTaxYearMinus4YearsAmt>653469</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>584320</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>813253</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>632596</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>1153960</CurrentTaxYearAmt>
        <TotalAmt>3837598</TotalAmt>
      </Total509Grp>
      <AmountsRcvdDsqlfyPersonGrp>
        <CurrentTaxYearMinus3YearsAmt>30470</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>60000</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>80176</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>131616</CurrentTaxYearAmt>
        <TotalAmt>302262</TotalAmt>
      </AmountsRcvdDsqlfyPersonGrp>
      <SubstantialContributorsAmtGrp>
        <TotalAmt>0</TotalAmt>
      </SubstantialContributorsAmtGrp>
      <SubstAndDsqlfyPrsnsTotGrp>
        <CurrentTaxYearMinus3YearsAmt>30470</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>60000</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>80176</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>131616</CurrentTaxYearAmt>
        <TotalAmt>302262</TotalAmt>
      </SubstAndDsqlfyPrsnsTotGrp>
      <PublicSupportTotal509Amt>3535336</PublicSupportTotal509Amt>
      <GrossInvestmentIncome509Grp>
        <CurrentTaxYearMinus4YearsAmt>140</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>3067</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>2245</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>72</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>28</CurrentTaxYearAmt>
        <TotalAmt>5552</TotalAmt>
      </GrossInvestmentIncome509Grp>
      <Post1975UBTIGrp>
        <TotalAmt>0</TotalAmt>
      </Post1975UBTIGrp>
      <InvestmentIncomeAndUBTIGrp>
        <CurrentTaxYearMinus4YearsAmt>140</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>3067</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>2245</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>72</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>28</CurrentTaxYearAmt>
        <TotalAmt>5552</TotalAmt>
      </InvestmentIncomeAndUBTIGrp>
      <NetIncomeFromOtherUBIGrp>
        <TotalAmt>0</TotalAmt>
      </NetIncomeFromOtherUBIGrp>
      <OtherIncome509Grp>
        <TotalAmt>0</TotalAmt>
      </OtherIncome509Grp>
      <TotalSupportCalendarYearGrp>
        <CurrentTaxYearMinus4YearsAmt>653609</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>587387</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>815498</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>632668</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>1153988</CurrentTaxYearAmt>
        <TotalAmt>3843150</TotalAmt>
      </TotalSupportCalendarYearGrp>
      <PublicSupportCY509Pct>0.91990</PublicSupportCY509Pct>
      <PublicSupportPY509Pct>0.99820</PublicSupportPY509Pct>
      <InvestmentIncomeCYPct>0.00140</InvestmentIncomeCYPct>
      <InvestmentIncomePYPct>0.00180</InvestmentIncomePYPct>
      <ThirtyThrPctSuprtTestsCY509Ind>X</ThirtyThrPctSuprtTestsCY509Ind>
    </IRS990ScheduleA>
    <IRS990ScheduleB documentId="IRS990ScheduleB" softwareId="21013475" softwareVersionNum="2021v4.1">
      <ContributorInformationGrp>
        <ContributorNum>RESTRICTED</ContributorNum>
        <ContributorBusinessName>
          <BusinessNameLine1>RESTRICTED</BusinessNameLine1>
        </ContributorBusinessName>
        <ContributorUSAddress>
          <AddressLine1>RESTRICTED</AddressLine1>
          <AddressLine2>RESTRICTED</AddressLine2>
          <City>RESTRICTED</City>
          <State>RESTRICTED</State>
          <ZIPCode>RESTRICTED</ZIPCode>
        </ContributorUSAddress>
        <TotalContributionsAmt>RESTRICTED</TotalContributionsAmt>
      </ContributorInformationGrp>
    </IRS990ScheduleB>
    <IRS990ScheduleG documentId="IRS990ScheduleG" softwareId="21013475" softwareVersionNum="2021v4.1">
      <MailSolicitationsInd>X</MailSolicitationsInd>
      <EmailSolicitationsInd>X</EmailSolicitationsInd>
      <PhoneSolicitationsInd>X</PhoneSolicitationsInd>
      <InPersonSolicitationsInd>X</InPersonSolicitationsInd>
      <SpecialFundraisingEventsInd>X</SpecialFundraisingEventsInd>
      <AgrmtProfFundraisingActyInd>false</AgrmtProfFundraisingActyInd>
      <FundraisingEventInformationGrp>
        <Event1Nm>TOURNAMENTS &amp; DINNER</Event1Nm>
        <GrossReceiptsEvent1Amt>236300</GrossReceiptsEvent1Amt>
        <CharitableContriEvent1Amt>167600</CharitableContriEvent1Amt>
        <GrossRevenueEvent1Amt>68700</GrossRevenueEvent1Amt>
        <FoodAndBeverageEvent1Amt>48052</FoodAndBeverageEvent1Amt>
        <OtherDirectExpensesEvent1Amt>186313</OtherDirectExpensesEvent1Amt>
        <Event2Nm>SILENT AND LIVE AUCTIONS</Event2Nm>
        <GrossReceiptsEvent2Amt>192230</GrossReceiptsEvent2Amt>
        <CharitableContriEvent2Amt>192230</CharitableContriEvent2Amt>
        <GrossReceiptsTotalAmt>428530</GrossReceiptsTotalAmt>
        <CharitableContributionsTotAmt>359830</CharitableContributionsTotAmt>
        <GrossRevenueTotalEventsAmt>68700</GrossRevenueTotalEventsAmt>
        <FoodAndBeverageTotalEventsAmt>48052</FoodAndBeverageTotalEventsAmt>
        <OthDirectExpnssTotalEventsAmt>186313</OthDirectExpnssTotalEventsAmt>
        <DirectExpenseSummaryEventsAmt>234365</DirectExpenseSummaryEventsAmt>
        <NetIncomeSummaryAmt>-165665</NetIncomeSummaryAmt>
      </FundraisingEventInformationGrp>
      <GamingInformationGrp>
        <VolunteerLaborBingoInd>false</VolunteerLaborBingoInd>
        <VolunteerLaborPullTabsInd>false</VolunteerLaborPullTabsInd>
        <GrossRevenueOtherGamingAmt>49695</GrossRevenueOtherGamingAmt>
        <VolunteerLaborOtherGamingInd>false</VolunteerLaborOtherGamingInd>
        <GrossRevenueTotalGamingAmt>49695</GrossRevenueTotalGamingAmt>
        <NetGamingIncomeSummaryAmt>49695</NetGamingIncomeSummaryAmt>
      </GamingInformationGrp>
      <StatesWhereGamingConductedCd>AZ</StatesWhereGamingConductedCd>
      <LicensedInd>false</LicensedInd>
      <ExplanationIfNoTxt>STATE OF ARIZONA DOES NOT REQUIRE A GAMING LICENSE TO RUN AONE-OFF RAFFLE.</ExplanationIfNoTxt>
      <LicenseSuspendedEtcInd>false</LicenseSuspendedEtcInd>
      <GamingWithNonmembersInd>true</GamingWithNonmembersInd>
      <MemberOfOtherEntityInd>false</MemberOfOtherEntityInd>
      <GamingOtherFacilityPct>1.00000</GamingOtherFacilityPct>
      <IndividualWithBooksNm>J DEREK HILL</IndividualWithBooksNm>
      <PersonsWithBooksUSAddress>
        <AddressLine1Txt>PO BOX 3740</AddressLine1Txt>
        <CityNm>CAREFREE</CityNm>
        <StateAbbreviationCd>AZ</StateAbbreviationCd>
        <ZIPCd>85377</ZIPCd>
      </PersonsWithBooksUSAddress>
      <CntrctWith3rdPrtyForGameRevInd>false</CntrctWith3rdPrtyForGameRevInd>
      <CharitableDistributionRqrInd>false</CharitableDistributionRqrInd>
    </IRS990ScheduleG>
    <IRS990ScheduleI documentId="IRS990ScheduleI" softwareId="21013475" softwareVersionNum="2021v4.1">
      <GrantRecordsMaintainedInd>true</GrantRecordsMaintainedInd>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>HONORHEALTH RESEARCH INST</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>8125 NORTH HAYDEN ROAD</AddressLine1Txt>
          <CityNm>SCOTTSDALE</CityNm>
          <StateAbbreviationCd>AZ</StateAbbreviationCd>
          <ZIPCd>85258</ZIPCd>
        </USAddress>
        <RecipientEIN>742355411</RecipientEIN>
        <CashGrantAmt>440000</CashGrantAmt>
        <NonCashAssistanceAmt>0</NonCashAssistanceAmt>
        <PurposeOfGrantTxt>SEED FUNDING-ASSISTANCE</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>MAYO CLINIC</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>13400 EAST SHEA BLVD</AddressLine1Txt>
          <CityNm>SCOTTSDALE</CityNm>
          <StateAbbreviationCd>AZ</StateAbbreviationCd>
          <ZIPCd>85262</ZIPCd>
        </USAddress>
        <RecipientEIN>416011702</RecipientEIN>
        <CashGrantAmt>440000</CashGrantAmt>
        <NonCashAssistanceAmt>0</NonCashAssistanceAmt>
        <PurposeOfGrantTxt>SEED FUNDING-ASSISTANCE</PurposeOfGrantTxt>
      </RecipientTable>
      <Total501c3OrgCnt>2</Total501c3OrgCnt>
      <TotalOtherOrgCnt>0</TotalOtherOrgCnt>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Additional Supplemental Information</FormAndLineReferenceDesc>
        <ExplanationTxt>Part I, Line 2 - Procedures for Monitoring the Use of Grant FundsThe CARE Funding Committee (comprised of doctors and other healthcare professionals) has ongoing meetings and discussions with all beneficiary institutions to monitor the progress &amp; results of programs/projects funded by CARE and conducts an annual review of proposals to continue support of existing projects for further advancement, or to consider new projects needing seed-funding to get them started. CARE's focus is to provide seed-funding for new, creative and innovative projects for the early detection, treatment, interception and cures for cancer. Projects funded by CARE enable the recipient organizations to demonstrate enough success, to then qualify for larger grants to significantly advance the research, clinical trials and expedite getting FDA approval for new cancer treatments and change "standards of care" protocols.Part IV-Additional InformationMAYO CLINIC OF ARIZONA-Purpose of grant-CARE provided seed-funding for the new INTERCEPT program to investigate sporadic/inhertied cancers.HONORHEATLH RESEARCH INSTITUTE-PURPOSE OF GRANT-provided seed-funding to advance the Cellular Therapy Research Program to advance CAR-t cell therapies, with initial focus on blood cancers.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleI>
    <IRS990ScheduleO documentId="IRS990ScheduleO" softwareId="21013475" softwareVersionNum="2021v4.1">
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part VI, Line 11b: Form 990 Review Process</FormAndLineReferenceDesc>
        <ExplanationTxt>A DRAFT OF THIS RETURN IS FIRST REVIEWED BY THE CHAIRPERSON AND THENDISTRIBUTED TO THE BOARD MEMBERS FOR REVIEW, QUESTIONS AND COMMENTS.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part VI, Line 12c: Explanation of Monitoring and Enforcement of Conflicts</FormAndLineReferenceDesc>
        <ExplanationTxt>ANNUALLY CARE DISTRIBUTES THE CONFLICT OF INTEREST POLICY TO EVERY BOARDMEMBER. ALL BOARD MEMBERS ARE REQUIRED TO ATTEST THAT THEY ARE INCOMPLIANCE WITH THE POLICY AND ARE REQUIRED TO SIGN A STATEMENT CONFIRMINGCOMPLIANCE. PRIOR TO THE ELECTION OF ANY NEW BOARD MEMBER, THEY TOOARE REQUIRED TO REVIEW THE POLICY AND SIGN A STATEMENT CONFIRMINGCOMPLIANCE. THE POLICY REQUIRES ANY TRANSACTIONS THAT INVOLVE A BOARDMEMBER, OR A RELATION OF A BOARD MEMBER, BE BROUGHT TO THE ATTENTION OF ANDAPPROVED BY THE BOARD TO APPROVE, PRIOR TO ENTERING INTO ANY TRANSACTION.ANY TRANSACTIONS THAT ARE DEEMED "MATERIAL", NOT CONSISTENT WITH MARKETPRICING, OR GREATER THAN 5% OF REVENUES, WILL NOT BE ENTERED INTO UNDER THEESTABLISHED POLICY. THE CARE SECRETARY MAINTAINS THE FILE OF DOCUMENTSSIGNED BY ANY BOARD MEMBERS CONFIRMING COMPLIANCE.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part VI, Line 19: Other Organization Documents Publicly Available</FormAndLineReferenceDesc>
        <ExplanationTxt>No documents available to the public.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Other Changes In Net Assets Or Fund Balances - Other Increases</FormAndLineReferenceDesc>
        <ExplanationTxt>prior year adjustment = $5673</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleO>
  </ReturnData>
</Return>
